3 Powerful Nuclear Energy Stocks to Buy in July

Nuclear power’s growth outlook is being re-priced by AI-led electricity demand and a U.S. push to quadruple nuclear capacity to 400 GWe by 2050, with the EIA projecting data-center server electricity use rising more than 16x vs. 2020 by 2050 in its High Electricity Demand case. Constellation (CEG) reported Q1 2026 adjusted EPS of $2.74 vs $2.60 consensus (+5% beat) on $11.12B revenue (+64% YoY) and guided 2026 adjusted operating EPS of $11.00-$12.00, but faces Calpine integration and a capacity-factor dip (92% from 94%). Cameco (CCJ) delivered a Q1 EPS beat (47c vs 34c, +38%) and guided 2026 revenue $3.13B-$3.37B with realized uranium price $85-$89/lb, while Oklo (OKLO) remains pre-revenue but has a ~14 GW customer pipeline (notably a 12 GW deal with Switch through 2044), making the setup high-beta and timing/financing-dependent.

Analysis

The cleanest expression here is not “nuclear” broadly, but quality versus option value. CEG has the best near-term monetization path because it turns power scarcity into contracted cash flow, while CCJ is a slower-moving tollbooth on the fuel cycle that benefits if the market keeps rewarding visible supply security over spot uranium beta. OKLO is still mostly a funding and permitting story; in the next 6-12 months, sentiment can outrun fundamentals, but the burden of proof remains on execution rather than addressable demand.

Second-order winners are hyperscalers with explicit power access and the suppliers that can de-risk their load growth; losers are data-center and colocation names without secured generation, because incremental power capex and grid delays can erode returns faster than revenue grows. That argues for watching EQIX and the broader AI infra complex for multiple compression if investors start applying a higher “power certainty” discount to unlabeled capacity. If the market starts valuing electrons as a scarce input, the advantage shifts toward owners of dispatchable baseload, not developers selling a future promise.

The main near-term risk is that the market has already partially moved on the story, so upside depends on fresh catalysts: another PPA, guidance raise, uranium spot confirmation, or NRC milestones. The contrarian view is that the consensus may be extrapolating 2030s demand into 2026 valuations too aggressively; if AI capex slows or power project timelines slip, the whole basket can de-rate even if the secular thesis stays intact.

Key Decisions for Investors

• Long CEG on a 1-3 month horizon; best risk/reward among the group because cash flow is already visible. Falsify if fleet reliability slips again or integration leverage pushes management to temper 2026-2029 growth guidance.
• Pair trade: long CEG / short OKLO. Use it as a quality-vs-convexity spread; if the market rotates from narrative to execution, CEG should outperform while OKLO remains financing/NRC-sensitive. Reassess if OKLO announces a non-dilutive financing package or major regulatory milestone.
• Hold CCJ as a slower thesis on uranium re-rating, but size it smaller than CEG. Upside depends on sustained long-term contract pricing and not just spot moves; fade if uranium spot stalls below recent highs or if maintenance/tax overhangs widen.
• Avoid chasing EQIX solely on the nuclear thesis; it is a beneficiary of AI demand but also exposed to power procurement costs and capex intensity. Use any strength to hedge if you want AI infrastructure exposure without paying for peak multiple expansion.
• Watch for a catalyst basket: new hyperscaler PPAs, NRC approvals, or a guidance raise in the next earnings cycle. If none appear by 1-2 quarters, expect the trade to become more range-bound and valuation-driven.